• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    紅內期瘧疾疫苗的研究進展

    2011-08-15 00:44:39陳琳黃復生
    成都醫(yī)學院學報 2011年2期
    關鍵詞:陳琳第三軍醫(yī)大學教研室

    陳琳,黃復生

    (第三軍醫(yī)大學基礎部病原生物學教研室,重慶 400038)

    Background

    Malaria remains one of the global devastating infectious disease,and results in 300-500 million clinical cases and nearly one million deaths annually worldwide[1,2].There are five species of Plasmodium parasites transmitted to humans:P.falciparum,P.vivax,P.ovale,P.malariae and P.knowlesi.P.falciparum is associated with the great majority of morbidity and mortality in human parasite,whereas P.vivax causes considerable symptomatic disease.Malaria is a mosquito-borne disease,and the parasite's sporozoites(SPZ)invade blood vessels and are transported to the liver after bitten by infected Anopheles mosquitoes.Here they infect hepatocytes,replicate and form a liver stage(LS)that grows asymptomatically.The blood-stage of the lifecycle commences when merozoites are released from the individual hepatocyte and infect erythrocytes.Red blood cell invasion is thought to involve multi-step process that several proteins at the parasite and erythrocyte surface receptor-ligand interaction[3].Once inside the red blood cell,parasites are partially hidden from immune recognition because erythrocytes lack a nucleus and major histocompatibility complex molecules.The parasites express proteins on the surface of infected erythrocyte and exposed to the immune system.

    Human repeated exposure to malaria parasites can naturally acquire immune and predominantly target the blood-stage parasites[4,5].Humoral-and cell-mediated immune responses play crucial roles in protective immunity against malaria parasites.But the immune effector mechanisms and the correlates of protection are poorly understood.It is suggested by passive immunoglobulin-transfer studies that antibodies are crucial components in blood-stage protective immunity,which may play a role in preventing merozoites invasion,antibody-dependent cell-mediated cytotoxity and greater clearance of infected red blood cell[6].With the development of resistance of malaria parasites to drugs and resistance of mosquitoes to insecticides,a cheap,broadly protective malaria vaccine is urgently required.A high level of antigenic diversity,redundancy of parasite invasion pathways and mechanisms of immune evasion pose significant challenges for vaccine development.The purpose of this review is to focus on the development of blood-stage vaccines,the advantages and challenges of this approach,potential target antigens expressed in the blood-stage and future directions.

    1 Potential targets

    The greatest challenge for developing effective blood-stage vaccine is the antigen diversity and identification of potential targets[7,8].At present,Merozoite surface proteins,as initial attachment antigens,and whole blood-stage parasites are the most promising candidates in blood-stage vaccine.

    1.1 Merozoite surface protein 1(MSP1)

    MSP1 is GPI(glycosylphosphatidylinositol)anchored to the merozoite surface and a 200 kDa polymorphic protein which undergoes proteolytic processing into four fragments p83,p30,p38,and p42.MSP1-42 undergoes secondary processing into two fragments p19 and p33.MSP1,which is important for the invasion process of erythrocytes by merozoite,is considered a prime candidate antigen for a blood stage vaccine.Several lines of evidence indicated thatthe C-terminal region of MSP1(MSP1-19 and-42)demonstrated the high antigenicity,and the naturally acquired antibodies to the C-terminus can inhibit the erythrocyte invasion and MSP processing[9,10].Therefore,both MSP1-42 and MSP1-19 fragments are thought to be the most advanced candidates for MSP1 vaccine development.But anti-MSP1-42 sera demonstrated strain-specific protection for P.falciparum-Aotus challenge model,and a PhaseⅡb trial of MSP1-42 in Kenyan found no protective effect[11].Antigen diversity was thought to a be major reason of failure of the vaccine.The study of genetic diversity in coding regions of PvMSP1-42 showed that 19kDa fragment at amino acid level was highly conserved in Sri Lankan isolates,whereas 33kDa fragment demonstrated extensive genetic diversity[12].But the opposite pattern was observed in P.falciparum[13].These observations indicate that the immunological interference between epitopes of PvMSP1-19 and PvMSP1-33 may affect the protection of PvMSP1-42 vaccine and a vaccine based on PvMSP1-19 alone could be effective against P.vivax infections in Sri Lankan.However,the analysis of antibody responses to PfMSP1-19 variant forms suggested the presence of cross-reactive antibody responses and non-variant specific antibodies to PfMSP1-19 in I-ranian individual infected by P.falciparum.One variant of this antigen,especially Q/KNG/L,may be sufficient for developing a PfMSP1-19-based vaccine[14].A study by Woehlbier showed that antibody elicited by entire MSP molecule can efficiently inhibit parasite multiplication and RBC invasion.Moreover,anti-MSP-1D antibodies would provide cross-protection for FCB-1 strain,a representative of K1 prototype.This study may provide the possibility of developing a vaccine based on the fullsize MSP1[15].

    1.2 Merozoite surface protein 2

    Merozoite surface protein 2(MSP-2)is a highly polymorphic 45-53 kDa protein,which like MSP-1,is also GPI anchored to the merozoite surface.High IgG3 antibody titers to MSP2 suggested that the molecule might be involved in protective immunity against P.falciparum[16,17].The N-and C-terminal domains of two allelic families,3D7 and FC27,are highly conserved with a variable region composed of central repeat region.MSP-2 was an important component in Combination B,including full-length 3D7 MSP2,block 2,3 of MSP1 and ring-infected erythrocyte surface antigen(RESA)formulated with the Montanide ISA720[18].A phase I/IIb field trial involving 120 children living in an area of Papua New Guinea reported that parasite densities were significantly decreased(62%)in the vaccine recipients[19].Furthermore,the activity of MSP-2 subunit included in the vaccine couldn't pro-tect against MSP-2 allelic family(FC27),suggesting that the major component of protective effect in Combination B was MSP-2[20].T he success of Combination B makes it possible that MSP-2 may be the most promising candidate antigen.Inclusion of both allelic variant in MSP-based vaccine could give the higher protective efficacy.Flueck found that two MSP-2 long synthetic peptides(LSP),comprising the semi-conserved family-specific domain plus the C-terminal domain of the two allelic families,could yield high titer antibody responses,and the response was associated with protective effect[21].However,MSP-2 is an intrinsically unstructured protein,which contains a single intramolecular disulphide bond and lacks hydrophobic residues.The lack of the structure knowledge of MSP-2 is the major hurdle to presume that an MSP-2 fragment will be as effective as the fulllength protein to induce a high antibody response.

    1.3 Merozoite surface protein 3

    Merozoite surface protein 3(MSP-3)is associated with merozoite surface through the non-covalent linkages and has been suggested to be involved in erythrocyte binding,although its function is unknown[22].Structurally,the C-terminal domain containing leucine zipper sequence is entirely conserved,whereas N-terminal region comprised of three blocks of heptad repeats is relatively polymorphic,which define two allele classes termed 3D7 and K1[23].The naturally acquired MSP-specific IgG3 antibody has strong antiparasitic effect in P.falciparum infected children.The cytophilic antibodies inhibited intra-erythrocytic parasite growth in a monocyte-dependent manner[24].In ADCI assays,amino acid residues 194 to 257 in C-terminal domain have been shown to exert a strong inhibition activity against P.falciparum parasite growth.MSP-3,as a long synthetic peptide,underwent a Phase Ib clinical trial among Tanzanian children and Burkina Faso adult males.The result showed that the MSP3-LSP vaccine with two adjuvants,Montanide ISA and aluminium hydroxide,was safe and immunogenic even at low dose in a malaria-na?ve population.Further studies are to define the true protective effects through Phase II clinical trial[25,26].However,recent studies demonstrated that the N-terminal domain of PfMSP3 is significantly more immunogenic than the C-terminal region.Antibody responses to N-terminal domain were largely allele specific and no been found allele specific within each allele class.These data raise the possibility for development of any PfMSP3 N-terminal domain-based vaccine[27,28].

    1.4 Apical membrane antigen-1

    AMA1 is thought to play an essential role in erythrocyte invasion.However,it is highly polymorphic and allelic-specific antibodies are not cross-protective[29].AMA1-C1 contains sequences from the FVO and 3D7 allelic form,adjuvanted with alhydrogel,and has progressed though Phase I/II trial in Mali.But the antibody levels were not maintained.Adding CPG 7909 to the AMA1/Alhydrogel formulation can improve immunogenicity[30].A vaccine containing the FVO form with three different adjuvants,including Alhydrogel,Montanide ISA 720 and ASO2A,Phase I clinical trail is ongoing and the highest antibody response were induced by ASO2A formulations[31].

    1.5 P.falciparum erythrocyte membrane protein-1

    P.falciparum erythrocyte membrane protein-1(PfEMP1)family is expressed on the surface of infected erythrocytes.PfEMP1 is encoded by 60 or more var genes.And different var genes encode PfEMP1 variants with different antigenic properties[32].The extreme variability of this antigen is a challenge for the development of a highly effective vaccine.The success of a subunit vaccine depended on its ability to elicit cross-reactive responses to different variants.A specific variant of PfEMP1,VAR2CSA,is thought to mediate parasite sequestration in the placenta and less antigenically diverse than other PfEMP1 variants.T he antibody raised against VAR2CSA is cross-reactive with different placental-binding isolates,showing that the development of an effective vaccine based on the conversed epitopes of VAR2CSA is possible[33].

    2 Whole blood-stage parasites approach

    Owing to the success of radiation-attenuated sporozoite studies,the whole-parasite vaccine has regained attention.There is evidence that na?ve adult human volunteers infected with a low dose of live P.falciparum parastes can develop cell-mediated immune response and ultra-low doses of irradiated or CpG adjuvanted killed parasites can induce cellular immunity against both heterologous and homologous parasites in animal models[34,35].The whole-parasite vaccine is likely to involve a vast array antigens,thus reducing the impact of antigenic polymorphisms.More recently,study has suggested that crude extract from Pf whole-parasite could elicit parasite antigen-specific immune response via Toll-like receptor(T LR)9,by adjuvanted with the malaria heme-detoxification byproduct,hemozoin(HZ).A synthetic HZ could be used as an adjuvant to improve immunogenicity of whole-parasite vaccines[36].However,the safety and large-scale production of whole-parasite vaccine is an important challenge for the widespread use.

    3 Challenges and future directions

    There are many evidences supporting the development of a vaccine based on blood-stage parasite antigens.However,the recent two Phase II clinical trials show no protective efficacy in African children.One possible hurdle for development of the blood-stage vaccine is the difference in parasitespecific,immune and pathogenic responses to malaria parasites between mice and humans.Recently,efforts are also going toward"humanize"the mouse model that a valid approach to evaluate blood-stage vaccine,but further studies are needed to evaluate their relevance.However,the greatest challenge for blood-stage vaccine development is perhaps highly antigenic polymorphism.Multiple antigens or allelic forms are possible required in a single vaccine to overcome the challenge.More knowledge on identification of potential antigens as blood-stage vaccine candidate isneeded.Highthroughput serological screening of whole plasmodium proteomes might guide vaccine and diagnostic antigen discovery[37].

    4 Conclusion

    In this review,we have highlighted the development and challenge of leading blood-stage candidate vaccine.Many target antigens expressed on the surface of merozoites have been demonstrated that antibodies to these proteins can confer protection against homologous parasite challenge.However,so far,no recombinant protein has been proved sufficiently efficacious in human test.Effective blood-stage vaccines will almost certainly need to choose several different antigens or several allelic types to overcome antigenic diversity.Therefore,there is a strong need for identification of a multitude of new antigens from genomic and proteomic insights.Recently,efforts are also underway to reexamine whole blood-stage parasite vaccines.We remain optimistic about the development of bloodstage vaccines against malaria and a highly effective vaccine is possible.

    [1]Snow RW,Guerra CA,Noor AM,et al.The g lobal distribution of clinical episodes of Plasmodium falciparum malaria[J].Nature,2005,434(7030):214-217.

    [2]Guerra CA,Gikandi PW,T atem AJ,et al.The limits and intensity of Plasmodium falciparum transmission:implications for malaria control and elimination worldwide[J].PLoS Med,2008,5(2):38.

    [3]Gilson PR,Crabb BS.Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites[J].International Journal for Parasitology,2009,39(1):91-96.

    [4]Marsh K,Snow RW.Host-parasite interaction and morbidity in malaria endemic areas[J].Philosophical Transactions of the Royal Society of London Series B Biological Sciences,1997,352(1359):1385-1394.

    [5]Doolan DL,Dobano C,Baird JK.Acquired immunity to malaria[J].Clin Microbiol Rev,2009,22(1):13-36.

    [6]Langhorne J,Ndungu FM,Sponaas AM,et al.Immunity to malaria:more questions than answers[J].Nat Immunol,2008,9(7):725-732.

    [7]Volkman SK,Hartl DL,Wirth DF,et al.Ex cess polymorphisms in genes for membrane proteins in Plasmodium falciparum[J].Science,2002,298(5591):216-218.

    [8]Polley SD,Conway DJ.Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen 1 gene[J].Genetics,2001,158(4):1505-1512.

    [9]John CC,O'Donnell RA,Sumba PO,et al.Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1(MSP-1 19)can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa[J].J Immunol,2004,173(1):666-72.

    [10]O'Donnell RA,de Koning-Ward TF,Burt RA,et al.A ntibodies against merozoite surface protein(M SP)-19 are a major component of the invasion-inhibitory response in individuals immune to malaria[J].J.Ex p.Med,2001,193(12):1403-1412.

    [11]Ogutu BR,Apollo OJ,Mckinney D,et al.Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya[J].P LoS One,2009,4(3):4708.

    [12]Dias S,Longacre S,Escalante AA,et al.Genetic diversity and recombination at the C-terminal fragment of the merozoite surface protein-1 of Plasmodium vivax(PvMSP-1)in Sri Lanka[J].Infect Genet Evol,2011,11(1):145-156.

    [13]Pacheco MA,Poe AC,Collins WE,et al.A comparative study of the genetic diversity of the 42 kDa fragment of the merozoite surface protein-1 in Plasmodium falciparum and P.vivax[J].Infect.Genet.Evol,2007,7(2):180-187.

    [14]Zakeri S,Mehrizi AA,Zoghi S,et al.Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum(PfMSP-1(19))in Iranians ex posed to unstable malaria transmission[J].Malar J,2010,9(9):257-263.

    [15]Woehlbier U,Epp C,Kauth CW,et al.Analysis of Antibodies Directed against Merozoite Surface Protein 1 of the Human M alaria Parasite Plasmodium falciparum[J].Infec Immun,2006,74(2):1313-1322.

    [16]M etzger WG,Okenu DM,Cavanagh DR,et al.Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria[J].Parasite Immunol,2003,25(6):307-312.

    [17]Stanisic DI,Richards JS,McCallum FJ,et al.IgG subclassspecific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness[J].Infect Immun,2009,77(3):1165-1174.

    [18]Genton B,Al-Yaman F,Betuela I,et al.Safety and immunogenicity ofa three-componentblood-stage malaria vaccine(MSP1,MSP2,RESA)against Plasmodium falciparum in Papua New Guinean children[J].Vaccine,2003,22(1):30-41.

    [19]Genton B,Betuela I,Felger I,et al.A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea[J].J Infect Dis,2002,185(6):820-827.

    [20]Fluck C,Schopflin S,Smith T,et al.Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity[J].Infect Genet Evol,2007,7(1):44-51.

    [21]Flueck C,Frank G,Smith T,et al.Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates[J].Vaccine,2009,27(20):2653-2661.

    [22]Rodriguez LE,Curtidor H,Ocampo M,et al.Identifying Plasmodium falciparum merozoite surface antigen 3(MSP3)protein peptides that bind specifically to erythrocy tes and inhibit merozoite invasion[J].Protein Sci,2005,14(7):1778-1786.

    [23]Huber W,Felger I,Matile H,et al.Limited sequence polymo rphism in the Plasmodium falciparum merozoite surface protein 3[J].Mol Biochem Parasitol,1997,87(2):231-234.

    [24]Roussilhon C,Oeuvray C,Mǜller-Graf C,et al.Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3[J].PLos M ed,2007,4(11):320.

    [25]Sirima SB,Nebie I,Ouedraogo A,et al.Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide(MSP3-LSP)malaria vaccine in healthy,semi-immune adult males in Burkina Faso,West Africa[J].Vaccine,2007,25(14):2723-2732.

    [26]Lusingu JP,et al.Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months[J].Malar J,2009,8(6):163-171.

    [27]Polley SD,Tetteh KK,Lloyd JM,et al.Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection[J].J Infect Dis,2007,195(2):279-287.

    [28]Jordan SJ,Oliveira AL,Hernandez JN,et al.Malaria Immunoepidemiology in Low Transmission:Correlation of Infecting Genotype and Immune Response to Domains of Plasmodium falciparum M erozoite Surface Protein 3[J].Infect Immun,2011,79(5):2070-2078.

    [29]Cortes A,Mellombo M,Mueller I,et al.Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AM A1[J].Infect Immun,2003,71(3):1416-1426.

    [30]Sagara I,Ellis RD,Dicko A,et al.A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel+CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults[J].Vaccine,2009,27(52):7292-7298.

    [31]Roestenberg M,Remarque E,de Jonge E,et al.Safety and immunogenicity of a recombinant Plasmodium falciparum AM A1 malaria vaccine adjuvanted with Alhydrogel,Montanide ISA 720 or AS02[J].PLoS One,2008,3(12):3960.

    [32]Scherf A,Lopez-Rubio JJ,Riviere L.Antigenic variation in Plasmodium falciparum[J].Annu Rev Microbiol,2008,62:445-470.

    [33]Elliott SR,Duffy MF,Byrne TJ,et al.Cross-reactive surface epitopes on chondroitin sulfate A-adherent Plasmodium falciparum-infected ery throcytes are associated with transcription of var2csa[J].Infect Immun,2005,73(5):2848-2856.

    [34]Pinzon-Charry,A.and Good,M.F.Malaria vaccines:the case for a wholeorganism approach[J].Expert Opin.Biol,2008,8(4):441-448.

    [35]Pombo DJ,Lawrence G,Hirunpetcharat C,et al.Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum[J].Lancet,2002,360(9333):610-617.

    [36]Coban C,Igari Y,Yagi M,et al.Immunogenicity of wholeparasite vaccines against Plasmodium falciparum involves malarial hemozoin and host T LR9[J].Cell Host Microbe,2010,7(1):50-61.

    [37]Davies DH,Liang X,Hernandez JE,et al.Profiling the humoral immune response to infection by using proteome microarray s:high-throughput vaccine and diagnostic antigen discovery[J].Proc Natl Acad Sci U S A,2005,102(3):547-552.

    猜你喜歡
    陳琳第三軍醫(yī)大學教研室
    海軍軍醫(yī)大學生理學教研室
    The Effects of θ on Stability in the θ-Milstein Method for Stochastic Differential Equations
    陳琳作品《一口清茶,板栗飄香》
    大眾文藝(2022年16期)2022-09-07 03:07:44
    海軍軍醫(yī)大學神經生物學教研室
    海軍軍醫(yī)大學免疫學教研室
    沒有絕對的天分,也沒有絕對的天才——指揮家陳琳專訪
    紅十字 從這里起飛 第三軍醫(yī)大學2017年運動會剪影
    解放軍健康(2017年3期)2017-11-23 02:19:52
    喜鵲 “驚魂”
    光明所系 幸福相托
    ——走進第三軍醫(yī)大學大坪醫(yī)院眼科??漆t(yī)院
    趣聞
    分憂(2014年9期)2014-09-22 04:55:36
    别揉我奶头~嗯~啊~动态视频| 丝袜美腿在线中文| 亚洲内射少妇av| 色精品久久人妻99蜜桃| 夜夜夜夜夜久久久久| 精品一区二区三区av网在线观看| 白带黄色成豆腐渣| 免费看a级黄色片| 亚洲自偷自拍三级| 最近在线观看免费完整版| 亚洲第一电影网av| av福利片在线观看| 日韩中字成人| 一区二区三区四区激情视频 | 精品久久久久久久久久久久久| 一个人看视频在线观看www免费| 全区人妻精品视频| 国产av在哪里看| 久久99热这里只有精品18| 最新中文字幕久久久久| 亚洲一级一片aⅴ在线观看| 欧美性猛交╳xxx乱大交人| 最近中文字幕高清免费大全6 | 午夜免费成人在线视频| 国产精品久久久久久久电影| 两个人的视频大全免费| 久久欧美精品欧美久久欧美| 亚洲国产精品sss在线观看| 97人妻精品一区二区三区麻豆| 九九久久精品国产亚洲av麻豆| 丰满的人妻完整版| 国产高清视频在线观看网站| 听说在线观看完整版免费高清| 少妇裸体淫交视频免费看高清| 亚洲黑人精品在线| 最近在线观看免费完整版| 可以在线观看的亚洲视频| 午夜亚洲福利在线播放| 亚洲av成人av| 免费电影在线观看免费观看| 国产国拍精品亚洲av在线观看| 婷婷精品国产亚洲av在线| 大型黄色视频在线免费观看| 三级国产精品欧美在线观看| 波野结衣二区三区在线| 精品久久久噜噜| 国产精品美女特级片免费视频播放器| 中亚洲国语对白在线视频| 熟女人妻精品中文字幕| 久久精品国产亚洲网站| 很黄的视频免费| 成熟少妇高潮喷水视频| 别揉我奶头 嗯啊视频| 老女人水多毛片| 亚洲午夜理论影院| 亚洲精品一卡2卡三卡4卡5卡| 一区二区三区激情视频| 99国产极品粉嫩在线观看| 久久婷婷人人爽人人干人人爱| 国产成年人精品一区二区| 狂野欧美激情性xxxx在线观看| 欧美性猛交╳xxx乱大交人| 日本欧美国产在线视频| 99热这里只有是精品在线观看| 亚洲成人久久爱视频| 亚洲真实伦在线观看| 天天躁日日操中文字幕| 欧美成人a在线观看| 18禁在线播放成人免费| 日本 欧美在线| 嫁个100分男人电影在线观看| 一个人观看的视频www高清免费观看| 成人无遮挡网站| 在线观看美女被高潮喷水网站| 国产av不卡久久| 黄片wwwwww| 国产伦精品一区二区三区视频9| 天堂动漫精品| 日本a在线网址| 亚洲精品久久国产高清桃花| 99热6这里只有精品| 在线播放国产精品三级| 国产伦精品一区二区三区四那| 欧美精品啪啪一区二区三区| 老熟妇仑乱视频hdxx| 搡女人真爽免费视频火全软件 | 久久欧美精品欧美久久欧美| 国产精品,欧美在线| 超碰av人人做人人爽久久| 国产精品美女特级片免费视频播放器| av在线老鸭窝| 亚洲av二区三区四区| 搡老岳熟女国产| 日韩欧美免费精品| 国产精品一区www在线观看 | 美女黄网站色视频| 日本爱情动作片www.在线观看 | 18禁黄网站禁片午夜丰满| 麻豆精品久久久久久蜜桃| 成人美女网站在线观看视频| 国语自产精品视频在线第100页| 神马国产精品三级电影在线观看| 亚洲av美国av| 日韩av在线大香蕉| 欧美丝袜亚洲另类 | 欧美黑人欧美精品刺激| a级毛片免费高清观看在线播放| 俺也久久电影网| 色视频www国产| 国产大屁股一区二区在线视频| 啦啦啦韩国在线观看视频| 国产精品不卡视频一区二区| 亚洲性久久影院| 成人av一区二区三区在线看| 国产免费av片在线观看野外av| 校园人妻丝袜中文字幕| 熟女人妻精品中文字幕| 亚洲一区高清亚洲精品| 久久中文看片网| 国产亚洲欧美98| aaaaa片日本免费| 亚洲av成人精品一区久久| 久久久久国内视频| 日本撒尿小便嘘嘘汇集6| 欧美最黄视频在线播放免费| 悠悠久久av| 真人做人爱边吃奶动态| 亚洲精品一卡2卡三卡4卡5卡| 男人舔奶头视频| 欧美日韩中文字幕国产精品一区二区三区| 久久国内精品自在自线图片| 观看免费一级毛片| 中国美女看黄片| 精品人妻一区二区三区麻豆 | 乱码一卡2卡4卡精品| 欧美日韩综合久久久久久 | 嫩草影院入口| 亚洲美女搞黄在线观看 | 精品久久国产蜜桃| 乱系列少妇在线播放| 日日夜夜操网爽| 一级黄色大片毛片| 我的女老师完整版在线观看| 极品教师在线免费播放| 成人鲁丝片一二三区免费| 久久久久久久久久成人| 婷婷精品国产亚洲av在线| 琪琪午夜伦伦电影理论片6080| 久久九九热精品免费| 啦啦啦韩国在线观看视频| 白带黄色成豆腐渣| 亚洲精品在线观看二区| 亚洲av免费在线观看| 国产黄色小视频在线观看| 久99久视频精品免费| 老女人水多毛片| 免费av不卡在线播放| 日本与韩国留学比较| 有码 亚洲区| 能在线免费观看的黄片| 国产又黄又爽又无遮挡在线| 亚洲av二区三区四区| 少妇丰满av| 两个人视频免费观看高清| 特大巨黑吊av在线直播| av福利片在线观看| 亚洲美女黄片视频| 成人午夜高清在线视频| 精品99又大又爽又粗少妇毛片 | 欧美xxxx黑人xx丫x性爽| bbb黄色大片| 久久久久久久亚洲中文字幕| 免费av不卡在线播放| 国产男靠女视频免费网站| 中文字幕熟女人妻在线| 国产欧美日韩一区二区精品| 国产色婷婷99| 亚洲国产高清在线一区二区三| 日韩欧美一区二区三区在线观看| 日韩av在线大香蕉| 国产视频内射| 午夜视频国产福利| 亚洲中文字幕日韩| 在线免费观看的www视频| 嫩草影院入口| 特大巨黑吊av在线直播| 国产精品不卡视频一区二区| 999久久久精品免费观看国产| 午夜a级毛片| 欧美成人性av电影在线观看| 韩国av在线不卡| 可以在线观看毛片的网站| 欧美激情久久久久久爽电影| 国产毛片a区久久久久| 免费看av在线观看网站| 啦啦啦啦在线视频资源| 中文字幕av在线有码专区| 国产av在哪里看| 精品一区二区免费观看| 美女高潮喷水抽搐中文字幕| 俄罗斯特黄特色一大片| 一区二区三区免费毛片| 国模一区二区三区四区视频| 欧美黑人欧美精品刺激| 日本一二三区视频观看| 亚洲av电影不卡..在线观看| 免费无遮挡裸体视频| 热99在线观看视频| 亚洲五月天丁香| 级片在线观看| 国产亚洲精品久久久久久毛片| 国产av在哪里看| 黄色视频,在线免费观看| 久久久久性生活片| 国产 一区 欧美 日韩| 免费观看在线日韩| 99久久中文字幕三级久久日本| 岛国在线免费视频观看| 女人被狂操c到高潮| 波多野结衣巨乳人妻| 国产av在哪里看| 一区二区三区四区激情视频 | 九九在线视频观看精品| 老师上课跳d突然被开到最大视频| 国产伦精品一区二区三区四那| 成年女人看的毛片在线观看| 国产精品久久久久久精品电影| 欧美成人一区二区免费高清观看| 日本在线视频免费播放| 在线a可以看的网站| 高清日韩中文字幕在线| 国产精品久久久久久av不卡| 欧美日韩亚洲国产一区二区在线观看| 黄色配什么色好看| 精品久久久久久久久亚洲 | av黄色大香蕉| 国产淫片久久久久久久久| 欧美日韩亚洲国产一区二区在线观看| 欧美日韩国产亚洲二区| 色在线成人网| 国产伦一二天堂av在线观看| 精品人妻视频免费看| 性插视频无遮挡在线免费观看| 国产精品电影一区二区三区| 亚洲精品日韩av片在线观看| 国产亚洲av嫩草精品影院| 91狼人影院| 九九久久精品国产亚洲av麻豆| 国产美女午夜福利| 成人高潮视频无遮挡免费网站| 亚洲综合色惰| 日韩 亚洲 欧美在线| 亚洲国产精品合色在线| 亚洲18禁久久av| 亚洲欧美激情综合另类| 黄色日韩在线| 欧美一区二区国产精品久久精品| 亚洲精品456在线播放app | 国内毛片毛片毛片毛片毛片| 蜜桃亚洲精品一区二区三区| 在线a可以看的网站| 国产黄a三级三级三级人| 国产人妻一区二区三区在| 真人做人爱边吃奶动态| 美女大奶头视频| 99riav亚洲国产免费| 成人一区二区视频在线观看| 免费看a级黄色片| 久久6这里有精品| 久久国产精品人妻蜜桃| 一区二区三区高清视频在线| 国产精品日韩av在线免费观看| 成年人黄色毛片网站| 国产精品电影一区二区三区| 国产三级在线视频| 国产精品久久久久久av不卡| 美女被艹到高潮喷水动态| 大型黄色视频在线免费观看| 亚洲最大成人av| 18禁黄网站禁片午夜丰满| 欧美人与善性xxx| 国内揄拍国产精品人妻在线| 可以在线观看的亚洲视频| 老司机深夜福利视频在线观看| 久久久成人免费电影| 一本一本综合久久| 99久久精品一区二区三区| 午夜影院日韩av| 中亚洲国语对白在线视频| 欧美最黄视频在线播放免费| 精品福利观看| 国产亚洲91精品色在线| 51国产日韩欧美| 国产毛片a区久久久久| 国产私拍福利视频在线观看| 无人区码免费观看不卡| 亚洲色图av天堂| 色综合站精品国产| 亚洲av电影不卡..在线观看| 国产老妇女一区| 久久婷婷人人爽人人干人人爱| 乱系列少妇在线播放| 国产精品99久久久久久久久| 日韩精品有码人妻一区| 久久久色成人| 不卡视频在线观看欧美| 九九久久精品国产亚洲av麻豆| 非洲黑人性xxxx精品又粗又长| 久久久久精品国产欧美久久久| 国内精品美女久久久久久| 美女xxoo啪啪120秒动态图| 日韩欧美在线二视频| 亚洲成人久久性| 天美传媒精品一区二区| 亚洲欧美日韩高清在线视频| 亚洲欧美日韩无卡精品| 国内精品宾馆在线| 国产伦在线观看视频一区| 精品国产三级普通话版| 人妻少妇偷人精品九色| 伊人久久精品亚洲午夜| 亚洲av免费在线观看| 最新在线观看一区二区三区| 久久香蕉精品热| 在线观看美女被高潮喷水网站| 亚洲美女搞黄在线观看 | 国产 一区精品| 男人的好看免费观看在线视频| 老师上课跳d突然被开到最大视频| 亚洲av中文av极速乱 | 黄色日韩在线| 日本精品一区二区三区蜜桃| 精品午夜福利视频在线观看一区| 麻豆久久精品国产亚洲av| 亚洲av第一区精品v没综合| 日韩欧美国产在线观看| 日韩精品青青久久久久久| 久久天躁狠狠躁夜夜2o2o| 国产伦精品一区二区三区四那| 日本 av在线| 51国产日韩欧美| 亚洲精品一卡2卡三卡4卡5卡| 欧美一区二区国产精品久久精品| 91精品国产九色| 999久久久精品免费观看国产| 午夜亚洲福利在线播放| 亚洲在线观看片| 色在线成人网| 最近最新免费中文字幕在线| 美女被艹到高潮喷水动态| 国产精品福利在线免费观看| 精品人妻视频免费看| 天天躁日日操中文字幕| 最近中文字幕高清免费大全6 | 欧美一级a爱片免费观看看| 91久久精品电影网| 最近最新免费中文字幕在线| 欧美绝顶高潮抽搐喷水| 我要看日韩黄色一级片| 黄色欧美视频在线观看| 美女大奶头视频| 偷拍熟女少妇极品色| 国产综合懂色| 无遮挡黄片免费观看| 国产高清视频在线观看网站| 精品午夜福利视频在线观看一区| 久久精品人妻少妇| 男女边吃奶边做爰视频| 精品久久久久久久久久免费视频| 黄色女人牲交| 国产精品伦人一区二区| 12—13女人毛片做爰片一| www.www免费av| 中文字幕高清在线视频| 日本精品一区二区三区蜜桃| 国产一区二区在线av高清观看| 国内精品久久久久久久电影| av.在线天堂| 舔av片在线| 又爽又黄a免费视频| 深夜a级毛片| 亚洲国产色片| 国产在视频线在精品| 国产 一区精品| 18禁黄网站禁片午夜丰满| 国产免费一级a男人的天堂| 97热精品久久久久久| 国产精品99久久久久久久久| 天堂√8在线中文| 国产av一区在线观看免费| 亚洲精品成人久久久久久| 精品人妻熟女av久视频| 在线观看66精品国产| 露出奶头的视频| 免费观看精品视频网站| 他把我摸到了高潮在线观看| 精品人妻熟女av久视频| 熟女电影av网| 99热网站在线观看| 色av中文字幕| 波野结衣二区三区在线| 我要看日韩黄色一级片| 欧美最黄视频在线播放免费| 他把我摸到了高潮在线观看| 91麻豆av在线| 日韩欧美国产一区二区入口| 国产人妻一区二区三区在| 小说图片视频综合网站| 日韩av在线大香蕉| 欧美绝顶高潮抽搐喷水| 欧美日韩中文字幕国产精品一区二区三区| 午夜精品一区二区三区免费看| 国产精品久久久久久精品电影| 色av中文字幕| 村上凉子中文字幕在线| 在线免费观看不下载黄p国产 | 精品欧美国产一区二区三| 白带黄色成豆腐渣| 精品免费久久久久久久清纯| 亚洲午夜理论影院| 欧美一区二区国产精品久久精品| 国内精品久久久久精免费| 亚洲美女视频黄频| 女人被狂操c到高潮| 国产爱豆传媒在线观看| 99久久精品国产国产毛片| 三级男女做爰猛烈吃奶摸视频| 嫩草影院新地址| 91在线观看av| 成年女人永久免费观看视频| 国内精品久久久久精免费| 免费av毛片视频| 色av中文字幕| 老熟妇仑乱视频hdxx| 午夜精品在线福利| 动漫黄色视频在线观看| 男女视频在线观看网站免费| 日日摸夜夜添夜夜添小说| 欧美成人一区二区免费高清观看| 黄色丝袜av网址大全| 草草在线视频免费看| 免费看日本二区| 2021天堂中文幕一二区在线观| 男人的好看免费观看在线视频| 看免费成人av毛片| 狠狠狠狠99中文字幕| 免费看光身美女| 国内毛片毛片毛片毛片毛片| 国产精品人妻久久久久久| 亚洲最大成人av| 真人做人爱边吃奶动态| 国产精品三级大全| 99久久精品一区二区三区| 精品久久国产蜜桃| 成人美女网站在线观看视频| 久久婷婷人人爽人人干人人爱| 特大巨黑吊av在线直播| 色在线成人网| 成年女人毛片免费观看观看9| 免费看光身美女| 亚洲七黄色美女视频| 特级一级黄色大片| 露出奶头的视频| 国产精品人妻久久久久久| 91久久精品国产一区二区三区| 日韩在线高清观看一区二区三区 | 舔av片在线| 欧美激情国产日韩精品一区| 超碰av人人做人人爽久久| 国产探花极品一区二区| 18禁在线播放成人免费| 天堂av国产一区二区熟女人妻| 欧美一区二区国产精品久久精品| 少妇的逼水好多| 欧美日韩中文字幕国产精品一区二区三区| 真人做人爱边吃奶动态| 九色成人免费人妻av| a级一级毛片免费在线观看| 99在线人妻在线中文字幕| 精品久久久久久久久久免费视频| 国产精品人妻久久久影院| 乱码一卡2卡4卡精品| 亚洲av美国av| 国产色婷婷99| 亚洲美女视频黄频| 中文在线观看免费www的网站| 色综合亚洲欧美另类图片| 国产色爽女视频免费观看| 十八禁网站免费在线| 亚洲欧美日韩高清在线视频| 国产主播在线观看一区二区| 久久99热6这里只有精品| 亚洲专区中文字幕在线| 美女 人体艺术 gogo| 久久久久久九九精品二区国产| 日本欧美国产在线视频| 亚洲国产高清在线一区二区三| 亚洲欧美清纯卡通| 不卡一级毛片| 精品欧美国产一区二区三| 免费在线观看影片大全网站| 99精品久久久久人妻精品| 欧美+亚洲+日韩+国产| 国产成人av教育| 又粗又爽又猛毛片免费看| 久久精品国产亚洲网站| 国产av在哪里看| 全区人妻精品视频| 春色校园在线视频观看| 亚洲国产高清在线一区二区三| 国产精品嫩草影院av在线观看 | 国产精品一区二区三区四区久久| 天堂网av新在线| 亚洲18禁久久av| 在线国产一区二区在线| 欧美一区二区国产精品久久精品| 中文字幕高清在线视频| 我要看日韩黄色一级片| 国产精品亚洲美女久久久| 深爱激情五月婷婷| 免费在线观看日本一区| 精品乱码久久久久久99久播| 天堂网av新在线| 色哟哟·www| netflix在线观看网站| 日本免费a在线| 亚洲va日本ⅴa欧美va伊人久久| 国产伦人伦偷精品视频| 白带黄色成豆腐渣| 一区二区三区免费毛片| 欧美三级亚洲精品| 国产精品一区www在线观看 | 99精品久久久久人妻精品| 男女啪啪激烈高潮av片| 久久久久性生活片| 少妇被粗大猛烈的视频| 精品99又大又爽又粗少妇毛片 | 乱码一卡2卡4卡精品| 精品久久久久久久久亚洲 | 国产私拍福利视频在线观看| 欧洲精品卡2卡3卡4卡5卡区| 精品一区二区免费观看| 淫妇啪啪啪对白视频| 亚洲av美国av| 免费一级毛片在线播放高清视频| a级毛片免费高清观看在线播放| 一个人看视频在线观看www免费| 成人午夜高清在线视频| 全区人妻精品视频| 午夜激情欧美在线| 日本与韩国留学比较| 国产久久久一区二区三区| 色吧在线观看| 成人精品一区二区免费| 欧美日韩乱码在线| 亚洲经典国产精华液单| 真人一进一出gif抽搐免费| 国产三级中文精品| 久久草成人影院| 男女做爰动态图高潮gif福利片| 国产又黄又爽又无遮挡在线| 国产av不卡久久| 尾随美女入室| 久久6这里有精品| 变态另类成人亚洲欧美熟女| a在线观看视频网站| 国产精品综合久久久久久久免费| 精品无人区乱码1区二区| 国产不卡一卡二| 久久人妻av系列| 麻豆国产97在线/欧美| 伦精品一区二区三区| 欧美一区二区国产精品久久精品| 麻豆一二三区av精品| 长腿黑丝高跟| 真人做人爱边吃奶动态| 亚洲欧美日韩卡通动漫| 国产老妇女一区| 中文字幕精品亚洲无线码一区| 亚洲美女黄片视频| 色尼玛亚洲综合影院| 久久精品影院6| 特级一级黄色大片| 欧美成人一区二区免费高清观看| 波野结衣二区三区在线| 一进一出抽搐动态| 日韩精品有码人妻一区| 免费观看精品视频网站| 天美传媒精品一区二区| 亚洲国产高清在线一区二区三| 一进一出抽搐动态| 少妇丰满av| 国产色爽女视频免费观看| 国产精品爽爽va在线观看网站| 久久久久久久久久成人| 亚洲va在线va天堂va国产| 亚洲精品亚洲一区二区| 亚洲久久久久久中文字幕| 男女做爰动态图高潮gif福利片| 国产高清三级在线| 91久久精品国产一区二区三区| 欧美日韩国产亚洲二区| 最近中文字幕高清免费大全6 | 长腿黑丝高跟| 欧美激情国产日韩精品一区| videossex国产| 国产乱人视频| 亚洲久久久久久中文字幕| 十八禁网站免费在线| 成人高潮视频无遮挡免费网站| 日韩欧美精品免费久久| 在线观看av片永久免费下载| 男人狂女人下面高潮的视频| 国产精品一及| 成人精品一区二区免费|